4893 items matching your search terms.

Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy

Forsblom, C Hiukka, A Leinonen, ES Sundvall, J Groop, PH Taskinen, MR

Fenofibrate treatment reduces the occurrence of recurrent cardiovascular events in patients with type 2 diabetes

Foucher, C Le Malicot, K Ansquer, JC Gebski, V Keech, A

Symptom burden among patients with platinum resistant/refractory recurrent ovarian cancer: stage 1 of the GCIG Symptom Benefit study

Friedlander, M Voysey, M King, M Stockler, M Oza, A Gillies, K Miller, B Donovan, H Martyn, J Butow, P

Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. An Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) study

Gainford, MC Tinker, A Carter, J Petru, E Nicklin, J Quinn, M Hammond, I Elit, L Lenhard, M Friedlander, M

Long-term cancer risk of immunosuppressive regimens after kidney transplantation

Gallagher, M. P. Kelly, P. J. Jardine, M. Perkovic, V. Cass, A. Craig, J. C. Eris, J. Webster, A. C.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010     DOI:10.1681/ASN.2009101043

Impact of first-line chemotherapy duration in metastatic breast cancer: a systematic review

Gennari, A Sormani, M Nanni, O Stockler, M Wilcken, N Puntoni, M Amadori, D De Censi, A Bruzzi, P

Sentinel node based management caused less arm swelling and better quality of life than routine axillary clearance: 3-year outcomes of the SNAC trial

Gill, PG Wetzig, N Ung, O CampBell, I Collins, J Sourjina, T Stockler, M

Development of a nomogram to predict overall survival in patients with locally advanced or metastatic gastrointestinal stromal tumour receiving first line treatment with imatinib

Goldstein, D Lee, CK Hui, Y Shah, B Yip, D McArthur, G

LAP 07: Randomized multicenter phase III study in patients with locally advanced adenocarcinoma of the pancreas: gemcitabine with or without chemoradiotherapy and with or without erlotinib

Goldstein, D Spry, N Padbury, R Kneebone, A Barbour, A Biankin, A Harris, D Wong, N Roff, K Shannon, Jenny

GOFURTGO trial: an AGITG multicentre phase II study of fixed-dose-rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of locally advanced pancreatic cancer

Goldstein, D van Hazel, G Selva-Nayagam, S Ackland, S Shapiro, J Carroll, S Cummins, M Brown, C Simes, RJ Spry, N

A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts

Griffiths, A Dyer, SM Lord, SJ Pardy, C Fraser, IS Eckermann, S
HUMAN REPRODUCTION, 2010     DOI:10.1093/humrep/dep418

Accelerated BEP for advanced germ cell tumours: an ongoing multicentre phase I–II trial

Grimison, PS Stockler, M Thomson, DB Friedlander, M Gebski, V Boland, AL Chatfield, M Rosenthal, M Gurney, H Wong, SS Toner, GC Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Accelerated BEP for advanced germ cell tumours: an ongoing multicentre phase I–II trial

Grimison, PS Thomson, DB Stockler, M Friedlander, M Gebski, V Boland, AL Chatfield, M Rosenthal, M Gurney, H Toner, GC Australian and New Zealand Urogenital and Prostate Cancer Trials Group,

Management of testicular cancer

Grimison, PS Toner, GC

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: updated analysis of a randomised trial

Grimison, PS; Stockler, MR; Thomson, DB; Olver, IN; Harvey, VJ; Gebski, VJ; Lewis, CR; Levi, JA; Boyer, MJ; Gurney, H; Craft, P; Boland, AL; Simes, RJ; Toner, GC
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010     DOI:10.1093/jnci/djq245